Polypharmacy Among Older Adults with Metabolic Dysfunction–Associated Steatotic Liver Disease - Top-Institutions - MDSpire

Polypharmacy Among Older Adults with Metabolic Dysfunction–Associated Steatotic Liver Disease

  • By

  • Melinda Wang

  • Leena Usman

  • Benjamin Cho

  • Kenneth Covinsky

  • Jennifer C. Lai

  • July 14, 2026

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    UCSF Health – University of California, San Francisco
    UCSF Health – University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Geriatrics
    • Liver Disease

  • #2

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Geriatrics
    • Liver Disease

Original Source(s)

Polypharmacy Among Older Adults with Metabolic Dysfunction–Associated Steatotic Liver Disease

  • by Melinda Wang, Leena Usman, Benjamin Cho, Kenneth Covinsky, Jennifer C. Lai

  • July 14, 2026

Related Content

Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer

A hybrid ViT-L/32–MaxViT-L architecture with adaptive gated fusion for multiclass gastrointestinal disease detection and multi-method post-hoc explainability

Advances in single-cell transcriptomic sequencing in hepatic echinococcosis